Jay Bradner

Jay Bradner is the president of research and development at Amgen, a leading global biotechnology company. He has been instrumental in shaping Amgen's research direction, particularly in the fields of genetic research and therapeutic development. As a strategic leader, he has emphasized the importance of genetic studies in advancing medical science and has expressed gratitude for the contributions of Kári Stefánsson in establishing deCODE Genetics as a leader in the field.